Longevity
Venture capitalPalo Alto · Pre-Seed–Series B · 2 people tracked
Investment thesis
Seed and Series A investor—the first specialist fund focused solely on treating aging as a disease—led by Laura Deming; portfolio companies have raised >$1B and produced multiple IPOs.
Team · 2 people
from the firm's website
Laura Deming joined a UCSF lab at 12 and founded a longevity fund at 17; she pairs deep biology with investing, treats aging as engineering, and authored 95+ intervention FAQ.
What they invest in
from 11 of 17 portfolio companiesBiotech ×11AI & Machine Learning ×5Longevity ×4Deep Tech ×3Healthtech ×3Medical Devices ×3Digital Health ×2
HQs:United States×8
Investments · 17 tracked
founders shown can be your intro pathArda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)Remi-Martin Laberge(Founder and Chief Technology Officer)
BoardVineeta Agarwala(Director)
Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions.
AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesAlameda, US
Max Hodak(Chief Executive Officer)
Conception develops stem cell technology to create functional reproductive cells in the laboratory, enabling in-vitro gametogenesis as a solution for individuals facing biological and medical fertility barriers.
BiotechDeep TechHealthtech
Matt Krisiloff(CEO)Bianka Seres(President)
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)inDylan Morris(Director)in
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Gordian uses a proprietary in vivo drug discovery platform to identify therapeutic targets and treatments for complex age-related diseases.
AI & Machine LearningBiotechLongevity
BiotechSan Diego, US
Kristina Burow(Director)Trisha Millican(Executive Officer)Ken Song(Executive Officer, Director)Richard Heyman(Director)Amir Nashat(Director)Robert Adelman(Director)
BiotechCambridge, US
Jean-Francois Formela(Director)Rick Lundberg(Executive Officer)Alan Crane(Director)David Madden(Director)Marian Nakada(Director)Brian Gallagher(Director)
BiotechDurham, US
JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)TODD MELBY(Executive Officer)BEN AUSPITZ(Director)
BoardROBERT ADELMAN(Director)
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Frequently asked questions
- What stage does Longevity invest at?
- Longevity invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is Longevity's typical check size?
- Longevity typically writes checks of $100K – $1M.
- What sectors does Longevity focus on?
- Longevity focuses on AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech.
- Where is Longevity located?
- Longevity is headquartered in Palo Alto, US.
- Does Longevity lead rounds?
- Longevity typically participates in rounds rather than leading them.
Images
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
OMERS Ventures is the venture capital arm of the OMERS pension plan, investing in early-stage technology founders building solutions across North America and Europe.
Osage University Partners (OUP) is a venture capital firm that invests in startups emerging from leading research labs and universities, spanning technology and life sciences.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Blindspot Ventures is an infrastructure-focused technology investment fund that backs founders building foundational platforms, systems, and technologies for critical industries.